Veterinary Medicines

Cephacare flavour 250 mg tablets for dogs

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Cephacare flavour 250 mg tablets for dogs
Cephacare flavour 250 mg tablets for dogs
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    262.95
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Cephacare flavour 250 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 20 tablets.
  • Cephacare flavour 250 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 100 tablets.
  • Cephacare flavour 250 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 250 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • Produlab Pharma B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10491/005/002
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0454/002
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 6/04/2025
Download

Combined File of all Documents

English (PDF)
Published on: 6/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."